Cited by 695Radiomics and Machine Learning in Medical ImagingImage Retrieval and Classification TechniquesMedical Imaging Techniques and Applications

CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma

Open access
Coroller, Thibaud P., Grossmann, Patrick, Hou, Ying, Rios Velazquez, Emmanuel, Leijenaar, Ralph T.H., Hermann, Gretchen, Lambin, Philippe, Haibe-Kains, Benjamin +2 more·2015·Radiotherapy and Oncology

Abstract

Background and purpose Radiomics provides opportunities to quantify the tumor phenotype non-invasively by applying a large number of quantitative imaging features. This study evaluates computed-tomography (CT) radiomic features for their capability to predict distant metastasis (DM) for lung adenocarcinoma patients.Material and methods We included two datasets: 98 patients for discovery and 84 for validation. The phenotype of the primary tumor was quantified on pre-treatment CT-scans using 635 radiomic features. Univariate and multivariate analysis was performed to evaluate radiomics performance using the concordance index (CI).Results Thirty-five radiomic features were found to be prognostic (CI>0.60, FDR<5%) for DM and twelve for survival. It is noteworthy that tumor volume was only moderately prognostic for DM (CI=0.55, p-value=2.77×10(-5)) in the discovery cohort. A radiomic-signature had strong power for predicting DM in the independent validation dataset (CI=0.61, p-value=1.79×10(-17)). Adding this radiomic-signature to a clinical model resulted in a significant improvement of predicting DM in the validation dataset (p-value=1.56×10(-11)).Conclusions Although only basic metrics are routinely quantified, this study shows that radiomic features capturing detailed information of the tumor phenotype can be used as a prognostic biomarker for clinically-relevant factors such as DM. Moreover, the radiomic-signature provided additional information to clinical data.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2015.02.015

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the evaluation of lung cancer and glioblastoma multiforme, radiomics has been shown to be a tool with which to assess patient prognosis.

    “In the evaluation of lung cancer and in the evaluation of glioblastoma multiforme, radiomics has been shown to be a tool with which to assess patient prognosis (7).”

    From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [7]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Coroller, T. P., Grossmann, P., Hou, Y., Rios Velazquez, E., Leijenaar, R. T. H., Hermann, G., Lambin, P., Haibe-Kains, B., Mak, R. H., & Aerts, H. J. W. L.
Affiliations
  • Brigham and Women's Hospital (US)
  • Maastricht University (NL)
Corresponding author
  • Coroller, Thibaud P.
  • Aerts, Hugo J.W.L.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2015-03
Volume
114
Issue
3
Pages
345-350
ISSN
0167-8140 (ISSN-L)
OpenAlex
W1987054640
Cited by
695
References
42
Citations by year
2026: 15 · 2025: 39 · 2024: 51 · 2023: 37 · 2022: 70 · 2021: 97 · 2020: 97 · 2019: 98 · 2018: 72 · 2017: 71 · 2016: 33 · 2015: 13 · 2014: 1
FWCI
51.06
Type
journal article
Language
en
Open access
Locations
  • Radiotherapy and Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (acceptedVersion, other-oa)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Health Foundation Limburg
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (10696 DuCAT)
  • KWF Kankerbestrijding (UM 2009-4454, KWF MAC 2013-6089, 2011-5020, KWF UM 2009-4454, KWF UM 2011-5020, MAC 2013-6089, 2009-4454, 10696 DuCAT, 2013-6089)
  • National Institutes of Health (NIH-USA U01CA190234)
  • Stichting voor de Technische Wetenschappen (10696 DuCAT, 10696, n° 10696 DuCAT)
  • National Cancer Institute (U01CA190234)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Image Retrieval and Classification Techniques
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
lung adenocarcinoma, radiomics, distant metastasis prediction, CT imaging features, prognostic factors, tumor phenotype, survival prediction
MeSH terms
Adenocarcinoma of Lung, Adenocarcinoma, Adult, Aged, Aged, 80 and over, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Metastasis, Prognosis, Tomography, X-Ray Computed, Tumor Burden

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review